Predictive value of K-ras codon 12 mutation in ductal proliferative lesions of the pancreas.

被引:0
|
作者
Mulligan, NJ
Yang, S
Andry, C
Klein, M
O' Brien, MJ
机构
[1] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
[2] Vet Affairs Hosp, Dept Pathol, Boston, MA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:155A / 155A
页数:1
相关论文
共 50 条
  • [31] Detection of K.ras codon 12 point mutations and p53 overexpression in normal pancreatic tissue, hyperplastic and adenocarcinomatous lesions of the pancreas.
    Sauve, G
    Queneau, PE
    Viennet, G
    Koch, S
    Heyd, B
    Mantion, G
    Carayon, P
    Adessi, GL
    GASTROENTEROLOGY, 2000, 118 (04) : A1154 - A1154
  • [32] Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation
    De Jong, TA
    Skinner, SA
    Malcontenti-Wilson, C
    Vogiagis, D
    Bailey, M
    Van Driel, IR
    O'Brien, PE
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (02): : G266 - G272
  • [33] Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas
    Kitago, M
    Ueda, M
    Aiura, K
    Suzuki, K
    Hoshimoto, S
    Takahashi, S
    Mukai, M
    Kitajima, M
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) : 177 - 182
  • [34] K-ras mutations at codon 12 are rare events in chronic pancreatitis
    Orth, M
    Gansauge, F
    Gansauge, S
    Beger, HG
    Adler, G
    Schmid, RM
    DIGESTION, 1998, 59 (02) : 120 - 124
  • [35] K-RAS ONCOGENE CODON 12 POINT MUTATIONS IN TESTICULAR CANCER
    RIDANPAA, M
    LOTHE, RA
    ONFELT, A
    FOSSA, S
    BORRESEN, AL
    HUSGAFVELPURSIAINEN, K
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 : 185 - 187
  • [36] K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder
    Kim, SW
    Her, KH
    Jang, JY
    Kim, WH
    Kim, YT
    Park, YH
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (04) : 246 - 251
  • [37] Nonfunctioning islet cell carcinoma of the pancreas with high serum CEA & CA19-9, K-ras codon 12 mutation, and microsatellite instability
    Okai, T
    Kawashima, A
    Watanabe, H
    Takahashi, Y
    Sakai, J
    Ohtsubo, K
    Motoo, Y
    Matsui, O
    Murakami, S
    Nakabayashi, H
    Sawabu, N
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 30 (03) : 307 - 310
  • [38] LOWER INCIDENCE OF K-RAS CODON-12 MUTATION IN FLAT COLORECTAL ADENOMAS THAN IN POLYPOID ADENOMAS
    YAMAGATA, S
    MUTO, T
    UCHIDA, Y
    MASAKI, T
    SAWADA, T
    TSUNO, N
    HIROOKA, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (02): : 147 - 151
  • [39] HIGH-INCIDENCE OF POINT MUTATION IN K-RAS CODON-12 IN CARCINOMA OF THE FALLOPIAN-TUBE
    MIZUUCHI, H
    MORI, Y
    SATO, K
    KAMIYA, H
    OKAMURA, N
    NASIM, S
    GARRETT, CT
    KUDO, R
    CANCER, 1995, 76 (01) : 86 - 90
  • [40] Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas
    Kondo, H
    Sugano, K
    Fukayama, N
    Hosokawa, K
    Ohkura, H
    Ohtsu, A
    Mukai, K
    Yoshida, S
    CANCER, 1997, 79 (05) : 900 - 905